malaria_record: 126

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

This data as json

record_id country_id valid_from valid_to is_current source_id fetch_run_id payload_sha256 content_hash area_of_risk_html relative_risk_html chloroquine_resist_html species_html recommended_prophylaxis_html cdc_updated_date has_transmission is_endemic whole_country_endemic country_has_any_prophylaxis_area screening_class prophylaxis_drugs_json species_json chloroquine_resistant area_summary created_at
126 126 2026-06-03   1 1 1 8eab5796788447f748d742bc3ea9c689b7dd02e0761828d2fa9fd151f54f3515 e9b8ce551a0d58a8206d5b83d65f39624759afa72a1ba7819a9ef8638af0cf97
  • Primarily isolated to pockets in rural and forested areas
  • Rare cases in non-forested areas
  • No (or negligible) malaria transmission in the cities of Phnom Penh (the capital) and Siem Reap
  • No (or negligible) malaria transmission at the main temple complex at Angkor Wat
  
  • Chloroquine and mefloquine
  • P. vivax (95%)
  • P. falciparum (5%)
  • P. malariae and P. knowlesi6 (rare)
  • Rural and forested areas: Atovaquone-proguanil, doxycycline, primaquine5, tafenoquine2
  • Areas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
Updated April 23, 2025
 2025-04-23 1 1 0 1 partial ["atovaquone-proguanil", "doxycycline", "primaquine", "tafenoquine"] ["P. falciparum", "P. knowlesi", "P. malariae", "P. vivax"] 1 4 risk area statement(s) 2026-06-03T22:10:28Z

Links from other tables